Endothelium-dependent relaxation of porcine pulmonary arteries via 5-HT1C-like receptors

作者: Erika Glusa , Manfred Richter

DOI: 10.1007/BF00166737

关键词:

摘要: In PGF2α-precontracted pulmonary arteries with intact endothelium, 5-hydroxytryptamine (5-HT, 1.0-100 nmol/l) caused a concentration-dependent reversible relaxation, at higher concentrations the contractile response prevailed. endothelium-denuded vessels relaxation was absent. 5-HT-induced of precontracted probably mediated by release an endothelium-derived relaxing factor (EDRF). Preincubation methylene blue or NG-nitro-Lrarginine (200 μmol/l) attenuated relaxant effect. The accompanied increase in cGMP. Indomethacin (3 did not influence indicating that eicosanoids are involved to 5-HT. 5-HT1C and 5-HT2 receptor agonist α-methyl-5HT as potent 5-HT inducing relaxation. rank order potency agonists investigated α-methyl-5-HT > 5-methoxytryptamine tryptamine ω-methyl-5-HT 5-carboxamidotryptamine >2-methyl-5-HT 5,6-dihydroxytryptamine m-chlorophenylpiperazine >sumatriptan 8-OH-DPAT. Phentolamine, pindolol ICS 205-930 interfere antagonist ketanserin (1 inhibited but alter vasodilatation. Apart from blockade effects, mesulergine, cyproheptadine mianserin (0.1-3.0 μmol/l, each) induced parallel shift right concentration-response curve for a-methyl-5-HT Spiperone (0.3 exerted weak inhibitory effects on contraction. most (noncompetitive) against responses metitepine (0.1-1.0 which markedly depressed maximum effect agonists. failure inhibit suggests classical 5-HT3 receptors endothelium-dependent Comparison potencies antagonists their affinities brain binding sites revealed endothelial similar subtype. Furthermore, exhibit marked similarity recently cloned mediating contraction rat stomach fundus.

参考文章(34)
Robert R. Ruffolo, J. Paul Hieble, David P. Brooks, Giora Z. Feuerstein, Andrew J. Nichols, Drug receptors and control of the cardiovascular system: recent advances. Progress in drug research. ,vol. 36, pp. 117- 360 ,(1991) , 10.1007/978-3-0348-7136-5_4
Van Rossum Jm, Cumulative dose-response curves. II. Technique for the making of dose-response curves in isolated organs and the evaluation of drug parameters. Archives internationales de pharmacodynamie et de thérapie. ,vol. 143, pp. 299- 330 ,(1963)
H. O. Kalkman, J. R. Fozard, Further Definition of the 5-HT Receptor Mediating Contraction of Rat Stomach Fundus: Relation to 5-HT1D Recognition Sites Serotonin: Molecular Biology, Receptors and Functional Effects. pp. 153- 160 ,(1991) , 10.1007/978-3-0348-7259-1_14
M. Foguet, D. Hoyer, L.A. Pardo, A. Parekh, F.W. Kluxen, H.O. Kalkman, W. Stühmer, H. Lübbert, Cloning and functional characterization of the rat stomach fundus serotonin receptor. The EMBO Journal. ,vol. 11, pp. 3481- 3487 ,(1992) , 10.1002/J.1460-2075.1992.TB05427.X
Nicole Morel, Theophile Godfraind, Noradrenaline Modulates the Affinity of Dihydropyridines in Rat Aorta Blood Vessels. ,vol. 27, pp. 38- 38 ,(1990)
A. Lewis Farr, Oliver H. Lowry, Rose J. Randall, Nira J. Rosebrough, Protein Measurement with the Folin Phenol Reagent Journal of Biological Chemistry. ,vol. 193, pp. 265- 275 ,(1951)
P Schoeffter, D Hoyer, 5-Hydroxytryptamine (5-HT)-induced endothelium-dependent relaxation of pig coronary arteries is mediated by 5-HT receptors similar to the 5-HT1D receptor subtype. Journal of Pharmacology and Experimental Therapeutics. ,vol. 252, pp. 387- 395 ,(1990)
C. Waeber, P. Schoeffter, J.M. Palacios, D. Hoyer, Molecular pharmacology of 5-HT1D recognition sites: radioligand binding studies in human, pig and calf brain membranes. Naunyn-schmiedebergs Archives of Pharmacology. ,vol. 337, pp. 595- 601 ,(1988) , 10.1007/BF00175783
H. Prast, A. Philippu, Release of endogenous acetylcholine in the hypothalamus of conscious rats. Naunyn-schmiedebergs Archives of Pharmacology. ,vol. 346, pp. 1- 3 ,(1992) , 10.1007/BF00167562
Carl A. Gruetter, Sally M. Lemke, Bradykinin-induced endothelium-dependent relaxation of bovine intrapulmonary artery and vein European Journal of Pharmacology. ,vol. 122, pp. 363- 367 ,(1986) , 10.1016/0014-2999(86)90418-8